nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.306	0.5	CpDpCtD
Lidocaine—osteoarthritis—Prednisone—ankylosing spondylitis	0.306	0.5	CpDpCtD
Lidocaine—CYP2A6—Prednisolone—ankylosing spondylitis	0.0387	0.134	CbGbCtD
Lidocaine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0235	0.0809	CbGbCtD
Lidocaine—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0228	0.0788	CbGbCtD
Lidocaine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0202	0.0695	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0156	0.0538	CbGbCtD
Lidocaine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0156	0.0538	CbGbCtD
Lidocaine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0149	0.0513	CbGbCtD
Lidocaine—ABCB1—Betamethasone—ankylosing spondylitis	0.0131	0.0452	CbGbCtD
Lidocaine—ABCB1—Prednisolone—ankylosing spondylitis	0.0129	0.0446	CbGbCtD
Lidocaine—ABCB1—Prednisone—ankylosing spondylitis	0.0122	0.0421	CbGbCtD
Lidocaine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0121	0.0416	CbGbCtD
Lidocaine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0117	0.0404	CbGbCtD
Lidocaine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0113	0.0388	CbGbCtD
Lidocaine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00915	0.0316	CbGbCtD
Lidocaine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00786	0.0271	CbGbCtD
Lidocaine—CYP3A4—Betamethasone—ankylosing spondylitis	0.00785	0.0271	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—ankylosing spondylitis	0.00775	0.0267	CbGbCtD
Lidocaine—ABCB1—Dexamethasone—ankylosing spondylitis	0.00762	0.0263	CbGbCtD
Lidocaine—CYP3A4—Prednisone—ankylosing spondylitis	0.00732	0.0252	CbGbCtD
Lidocaine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00718	0.0248	CbGbCtD
Lidocaine—ABCB1—Methotrexate—ankylosing spondylitis	0.00613	0.0211	CbGbCtD
Lidocaine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00457	0.0157	CbGbCtD
Lidocaine—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000275	0.00279	CcSEcCtD
Lidocaine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000273	0.00277	CcSEcCtD
Lidocaine—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.000273	0.00277	CcSEcCtD
Lidocaine—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.000273	0.00277	CcSEcCtD
Lidocaine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000272	0.00277	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000269	0.00274	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000269	0.00274	CcSEcCtD
Lidocaine—Euphoric mood—Prednisone—ankylosing spondylitis	0.000269	0.00273	CcSEcCtD
Lidocaine—Sweating increased—Prednisolone—ankylosing spondylitis	0.000263	0.00267	CcSEcCtD
Lidocaine—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000261	0.00265	CcSEcCtD
Lidocaine—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000261	0.00265	CcSEcCtD
Lidocaine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.000254	0.00259	CcSEcCtD
Lidocaine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.000254	0.00259	CcSEcCtD
Lidocaine—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.000252	0.00256	CcSEcCtD
Lidocaine—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000249	0.00253	CcSEcCtD
Lidocaine—Asthma—Triamcinolone—ankylosing spondylitis	0.000248	0.00252	CcSEcCtD
Lidocaine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000248	0.00252	CcSEcCtD
Lidocaine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000248	0.00252	CcSEcCtD
Lidocaine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000244	0.00247	CcSEcCtD
Lidocaine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.000242	0.00246	CcSEcCtD
Lidocaine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000241	0.00245	CcSEcCtD
Lidocaine—Coma—Methotrexate—ankylosing spondylitis	0.000239	0.00243	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000236	0.0024	CcSEcCtD
Lidocaine—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000227	0.00231	CcSEcCtD
Lidocaine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.000222	0.00225	CcSEcCtD
Lidocaine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00022	0.00223	CcSEcCtD
Lidocaine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000219	0.00223	CcSEcCtD
Lidocaine—Sweating increased—Betamethasone—ankylosing spondylitis	0.000219	0.00223	CcSEcCtD
Lidocaine—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000217	0.00221	CcSEcCtD
Lidocaine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000217	0.0022	CcSEcCtD
Lidocaine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000216	0.0022	CcSEcCtD
Lidocaine—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000216	0.00219	CcSEcCtD
Lidocaine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000216	0.00219	CcSEcCtD
Lidocaine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000208	0.00211	CcSEcCtD
Lidocaine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000202	0.00205	CcSEcCtD
Lidocaine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000202	0.00205	CcSEcCtD
Lidocaine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.0002	0.00203	CcSEcCtD
Lidocaine—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.0002	0.00203	CcSEcCtD
Lidocaine—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000199	0.00202	CcSEcCtD
Lidocaine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000199	0.00202	CcSEcCtD
Lidocaine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000199	0.00202	CcSEcCtD
Lidocaine—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000199	0.00202	CcSEcCtD
Lidocaine—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000198	0.00201	CcSEcCtD
Lidocaine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000197	0.002	CcSEcCtD
Lidocaine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000197	0.002	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000196	0.00199	CcSEcCtD
Lidocaine—Sweating increased—Prednisone—ankylosing spondylitis	0.000191	0.00194	CcSEcCtD
Lidocaine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000191	0.00194	CcSEcCtD
Lidocaine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00019	0.00193	CcSEcCtD
Lidocaine—Erythema—Prednisolone—ankylosing spondylitis	0.000188	0.00191	CcSEcCtD
Lidocaine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000185	0.00188	CcSEcCtD
Lidocaine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000184	0.00187	CcSEcCtD
Lidocaine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000184	0.00186	CcSEcCtD
Lidocaine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000184	0.00186	CcSEcCtD
Lidocaine—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000181	0.00184	CcSEcCtD
Lidocaine—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000181	0.00184	CcSEcCtD
Lidocaine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00018	0.00183	CcSEcCtD
Lidocaine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00018	0.00183	CcSEcCtD
Lidocaine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00018	0.00183	CcSEcCtD
Lidocaine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000179	0.00182	CcSEcCtD
Lidocaine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000177	0.0018	CcSEcCtD
Lidocaine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000174	0.00176	CcSEcCtD
Lidocaine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000174	0.00176	CcSEcCtD
Lidocaine—Erythema—Triamcinolone—ankylosing spondylitis	0.000173	0.00176	CcSEcCtD
Lidocaine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000173	0.00175	CcSEcCtD
Lidocaine—Angioedema—Prednisolone—ankylosing spondylitis	0.000172	0.00175	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000171	0.00174	CcSEcCtD
Lidocaine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000169	0.00172	CcSEcCtD
Lidocaine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000168	0.00171	CcSEcCtD
Lidocaine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000168	0.00171	CcSEcCtD
Lidocaine—Back pain—Triamcinolone—ankylosing spondylitis	0.000167	0.0017	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000165	0.00168	CcSEcCtD
Lidocaine—Asthma—Methotrexate—ankylosing spondylitis	0.000164	0.00167	CcSEcCtD
Lidocaine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000164	0.00166	CcSEcCtD
Lidocaine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000164	0.00166	CcSEcCtD
Lidocaine—Convulsion—Prednisolone—ankylosing spondylitis	0.000163	0.00166	CcSEcCtD
Lidocaine—Hypertension—Prednisolone—ankylosing spondylitis	0.000162	0.00165	CcSEcCtD
Lidocaine—Bradycardia—Prednisone—ankylosing spondylitis	0.00016	0.00162	CcSEcCtD
Lidocaine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000158	0.00161	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000158	0.0016	CcSEcCtD
Lidocaine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000158	0.0016	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000157	0.00159	CcSEcCtD
Lidocaine—Erythema—Betamethasone—ankylosing spondylitis	0.000157	0.00159	CcSEcCtD
Lidocaine—Erythema—Dexamethasone—ankylosing spondylitis	0.000157	0.00159	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000153	0.00156	CcSEcCtD
Lidocaine—Oedema—Prednisolone—ankylosing spondylitis	0.000153	0.00156	CcSEcCtD
Lidocaine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000152	0.00154	CcSEcCtD
Lidocaine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000152	0.00154	CcSEcCtD
Lidocaine—Shock—Prednisolone—ankylosing spondylitis	0.000151	0.00153	CcSEcCtD
Lidocaine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00015	0.00152	CcSEcCtD
Lidocaine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00015	0.00152	CcSEcCtD
Lidocaine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000149	0.00152	CcSEcCtD
Lidocaine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000149	0.00151	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000148	0.00151	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—ankylosing spondylitis	0.000147	0.00149	CcSEcCtD
Lidocaine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000146	0.00149	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000146	0.00148	CcSEcCtD
Lidocaine—Flushing—Prednisone—ankylosing spondylitis	0.000146	0.00148	CcSEcCtD
Lidocaine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000143	0.00146	CcSEcCtD
Lidocaine—Angioedema—Betamethasone—ankylosing spondylitis	0.000143	0.00146	CcSEcCtD
Lidocaine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000142	0.00145	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—ankylosing spondylitis	0.000142	0.00145	CcSEcCtD
Lidocaine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000142	0.00144	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000142	0.00144	CcSEcCtD
Lidocaine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000141	0.00143	CcSEcCtD
Lidocaine—Oedema—Triamcinolone—ankylosing spondylitis	0.000141	0.00143	CcSEcCtD
Lidocaine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000141	0.00143	CcSEcCtD
Lidocaine—Shock—Triamcinolone—ankylosing spondylitis	0.000139	0.00141	CcSEcCtD
Lidocaine—Shock—Methylprednisolone—ankylosing spondylitis	0.000139	0.00141	CcSEcCtD
Lidocaine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000138	0.0014	CcSEcCtD
Lidocaine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000138	0.0014	CcSEcCtD
Lidocaine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000138	0.0014	CcSEcCtD
Lidocaine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000138	0.0014	CcSEcCtD
Lidocaine—Erythema—Prednisone—ankylosing spondylitis	0.000137	0.00139	CcSEcCtD
Lidocaine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000136	0.00139	CcSEcCtD
Lidocaine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000136	0.00138	CcSEcCtD
Lidocaine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000136	0.00138	CcSEcCtD
Lidocaine—Convulsion—Betamethasone—ankylosing spondylitis	0.000136	0.00138	CcSEcCtD
Lidocaine—Hypertension—Betamethasone—ankylosing spondylitis	0.000135	0.00138	CcSEcCtD
Lidocaine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000135	0.00138	CcSEcCtD
Lidocaine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000133	0.00135	CcSEcCtD
Lidocaine—Anxiety—Betamethasone—ankylosing spondylitis	0.000133	0.00135	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000132	0.00134	CcSEcCtD
Lidocaine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000132	0.00134	CcSEcCtD
Lidocaine—Pain—Prednisolone—ankylosing spondylitis	0.000131	0.00133	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000131	0.00133	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—ankylosing spondylitis	0.000129	0.00131	CcSEcCtD
Lidocaine—Oedema—Betamethasone—ankylosing spondylitis	0.000128	0.0013	CcSEcCtD
Lidocaine—Oedema—Dexamethasone—ankylosing spondylitis	0.000128	0.0013	CcSEcCtD
Lidocaine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000128	0.0013	CcSEcCtD
Lidocaine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000128	0.0013	CcSEcCtD
Lidocaine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000127	0.00129	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Shock—Betamethasone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Shock—Dexamethasone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Agitation—Prednisone—ankylosing spondylitis	0.000126	0.00128	CcSEcCtD
Lidocaine—Angioedema—Prednisone—ankylosing spondylitis	0.000125	0.00127	CcSEcCtD
Lidocaine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000124	0.00126	CcSEcCtD
Lidocaine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000124	0.00126	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000123	0.00125	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000122	0.00124	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—ankylosing spondylitis	0.000122	0.00124	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000122	0.00124	CcSEcCtD
Lidocaine—Pain—Triamcinolone—ankylosing spondylitis	0.000121	0.00123	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00012	0.00122	CcSEcCtD
Lidocaine—Hypotension—Betamethasone—ankylosing spondylitis	0.00012	0.00122	CcSEcCtD
Lidocaine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00012	0.00122	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000119	0.00121	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000119	0.0012	CcSEcCtD
Lidocaine—Convulsion—Prednisone—ankylosing spondylitis	0.000118	0.0012	CcSEcCtD
Lidocaine—Hypertension—Prednisone—ankylosing spondylitis	0.000118	0.0012	CcSEcCtD
Lidocaine—Chills—Methotrexate—ankylosing spondylitis	0.000118	0.0012	CcSEcCtD
Lidocaine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000116	0.00118	CcSEcCtD
Lidocaine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000116	0.00118	CcSEcCtD
Lidocaine—Anxiety—Prednisone—ankylosing spondylitis	0.000116	0.00118	CcSEcCtD
Lidocaine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000115	0.00117	CcSEcCtD
Lidocaine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000115	0.00117	CcSEcCtD
Lidocaine—Erythema—Methotrexate—ankylosing spondylitis	0.000114	0.00116	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000113	0.00115	CcSEcCtD
Lidocaine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000112	0.00114	CcSEcCtD
Lidocaine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000112	0.00114	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000112	0.00114	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000112	0.00113	CcSEcCtD
Lidocaine—Oedema—Prednisone—ankylosing spondylitis	0.000112	0.00113	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000111	0.00112	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000111	0.00112	CcSEcCtD
Lidocaine—Back pain—Methotrexate—ankylosing spondylitis	0.00011	0.00112	CcSEcCtD
Lidocaine—Shock—Prednisone—ankylosing spondylitis	0.00011	0.00111	CcSEcCtD
Lidocaine—Pain—Dexamethasone—ankylosing spondylitis	0.00011	0.00111	CcSEcCtD
Lidocaine—Pain—Betamethasone—ankylosing spondylitis	0.00011	0.00111	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000109	0.00111	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000108	0.0011	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000108	0.00109	CcSEcCtD
Lidocaine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000106	0.00107	CcSEcCtD
Lidocaine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000106	0.00107	CcSEcCtD
Lidocaine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000104	0.00106	CcSEcCtD
Lidocaine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000104	0.00105	CcSEcCtD
Lidocaine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000102	0.00103	CcSEcCtD
Lidocaine—Urticaria—Betamethasone—ankylosing spondylitis	0.000102	0.00103	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—ankylosing spondylitis	0.000101	0.00103	CcSEcCtD
Lidocaine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000101	0.00103	CcSEcCtD
Lidocaine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000101	0.00103	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—ankylosing spondylitis	0.0001	0.00102	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—ankylosing spondylitis	9.9e-05	0.00101	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—ankylosing spondylitis	9.72e-05	0.000988	CcSEcCtD
Lidocaine—Rash—Prednisolone—ankylosing spondylitis	9.68e-05	0.000983	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—ankylosing spondylitis	9.67e-05	0.000982	CcSEcCtD
Lidocaine—Headache—Prednisolone—ankylosing spondylitis	9.62e-05	0.000977	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—ankylosing spondylitis	9.4e-05	0.000955	CcSEcCtD
Lidocaine—Dizziness—Triamcinolone—ankylosing spondylitis	9.33e-05	0.000948	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.32e-05	0.000947	CcSEcCtD
Lidocaine—Dizziness—Methylprednisolone—ankylosing spondylitis	9.31e-05	0.000946	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—ankylosing spondylitis	9.19e-05	0.000934	CcSEcCtD
Lidocaine—Asthenia—Dexamethasone—ankylosing spondylitis	9.19e-05	0.000933	CcSEcCtD
Lidocaine—Asthenia—Betamethasone—ankylosing spondylitis	9.19e-05	0.000933	CcSEcCtD
Lidocaine—Nervous system disorder—Methotrexate—ankylosing spondylitis	9.14e-05	0.000929	CcSEcCtD
Lidocaine—Nausea—Prednisolone—ankylosing spondylitis	9.12e-05	0.000926	CcSEcCtD
Lidocaine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	9.01e-05	0.000915	CcSEcCtD
Lidocaine—Vomiting—Triamcinolone—ankylosing spondylitis	8.97e-05	0.000912	CcSEcCtD
Lidocaine—Vomiting—Methylprednisolone—ankylosing spondylitis	8.95e-05	0.00091	CcSEcCtD
Lidocaine—Rash—Triamcinolone—ankylosing spondylitis	8.9e-05	0.000904	CcSEcCtD
Lidocaine—Dermatitis—Triamcinolone—ankylosing spondylitis	8.89e-05	0.000903	CcSEcCtD
Lidocaine—Rash—Methylprednisolone—ankylosing spondylitis	8.88e-05	0.000902	CcSEcCtD
Lidocaine—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.87e-05	0.000901	CcSEcCtD
Lidocaine—Urticaria—Prednisone—ankylosing spondylitis	8.86e-05	0.0009	CcSEcCtD
Lidocaine—Headache—Triamcinolone—ankylosing spondylitis	8.84e-05	0.000898	CcSEcCtD
Lidocaine—Headache—Methylprednisolone—ankylosing spondylitis	8.82e-05	0.000896	CcSEcCtD
Lidocaine—Hypotension—Methotrexate—ankylosing spondylitis	8.71e-05	0.000885	CcSEcCtD
Lidocaine—Dizziness—Betamethasone—ankylosing spondylitis	8.47e-05	0.00086	CcSEcCtD
Lidocaine—Dizziness—Dexamethasone—ankylosing spondylitis	8.47e-05	0.00086	CcSEcCtD
Lidocaine—Nausea—Triamcinolone—ankylosing spondylitis	8.38e-05	0.000852	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—ankylosing spondylitis	8.37e-05	0.00085	CcSEcCtD
Lidocaine—Nausea—Methylprednisolone—ankylosing spondylitis	8.37e-05	0.00085	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—ankylosing spondylitis	8.31e-05	0.000844	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—ankylosing spondylitis	8.29e-05	0.000842	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—ankylosing spondylitis	8.22e-05	0.000835	CcSEcCtD
Lidocaine—Vomiting—Betamethasone—ankylosing spondylitis	8.14e-05	0.000827	CcSEcCtD
Lidocaine—Vomiting—Dexamethasone—ankylosing spondylitis	8.14e-05	0.000827	CcSEcCtD
Lidocaine—Rash—Betamethasone—ankylosing spondylitis	8.08e-05	0.00082	CcSEcCtD
Lidocaine—Rash—Dexamethasone—ankylosing spondylitis	8.08e-05	0.00082	CcSEcCtD
Lidocaine—Dermatitis—Betamethasone—ankylosing spondylitis	8.07e-05	0.00082	CcSEcCtD
Lidocaine—Dermatitis—Dexamethasone—ankylosing spondylitis	8.07e-05	0.00082	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.05e-05	0.000818	CcSEcCtD
Lidocaine—Headache—Betamethasone—ankylosing spondylitis	8.02e-05	0.000815	CcSEcCtD
Lidocaine—Headache—Dexamethasone—ankylosing spondylitis	8.02e-05	0.000815	CcSEcCtD
Lidocaine—Asthenia—Prednisone—ankylosing spondylitis	8e-05	0.000813	CcSEcCtD
Lidocaine—Pain—Methotrexate—ankylosing spondylitis	7.97e-05	0.00081	CcSEcCtD
Lidocaine—Feeling abnormal—Methotrexate—ankylosing spondylitis	7.68e-05	0.00078	CcSEcCtD
Lidocaine—Nausea—Dexamethasone—ankylosing spondylitis	7.61e-05	0.000773	CcSEcCtD
Lidocaine—Nausea—Betamethasone—ankylosing spondylitis	7.61e-05	0.000773	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—ankylosing spondylitis	7.4e-05	0.000752	CcSEcCtD
Lidocaine—Dizziness—Prednisone—ankylosing spondylitis	7.38e-05	0.000749	CcSEcCtD
Lidocaine—Vomiting—Prednisone—ankylosing spondylitis	7.09e-05	0.00072	CcSEcCtD
Lidocaine—Rash—Prednisone—ankylosing spondylitis	7.03e-05	0.000714	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—ankylosing spondylitis	7.03e-05	0.000714	CcSEcCtD
Lidocaine—Headache—Prednisone—ankylosing spondylitis	6.99e-05	0.00071	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.87e-05	0.000698	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—ankylosing spondylitis	6.69e-05	0.000679	CcSEcCtD
Lidocaine—Nausea—Prednisone—ankylosing spondylitis	6.62e-05	0.000673	CcSEcCtD
Lidocaine—Dizziness—Methotrexate—ankylosing spondylitis	6.16e-05	0.000626	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—ankylosing spondylitis	5.93e-05	0.000602	CcSEcCtD
Lidocaine—Rash—Methotrexate—ankylosing spondylitis	5.88e-05	0.000597	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—ankylosing spondylitis	5.87e-05	0.000596	CcSEcCtD
Lidocaine—Headache—Methotrexate—ankylosing spondylitis	5.84e-05	0.000593	CcSEcCtD
Lidocaine—Nausea—Methotrexate—ankylosing spondylitis	5.54e-05	0.000562	CcSEcCtD
